CRESP Darbepoetin Alfa Injection

Category:

DESCRIPTION

Cresp (Darbepoetin alfa) Injection is a prescription drug used to treat anemia due to chronic kidney disease or due to chemotherapy. Cresp 40mcg injection is an erythropoiesis-stimulating agent (ESA). It Stimulates bone marrow to produce more red blood cells.

Manufacturer : Dr Reddy’s Laboratories Ltd.

ADDITIONAL INFORMATION

Strengths available :  25mcg, 40mcg, 60mcg, 100mcg & 200mcg

Storage :  Store at temperature between 2°C – 8°C

Dosage :

Renal Anemia: Hemodialysis Patients:

The usual dose of Cresp in adult patients is 20 μg as Cresp (genetical recombination), to be administered as a single intravenous injection once weekly.

Peritoneal Dialysis Patients And Patients With Chronic Kidney Disease Not On Dialysis:

The usual dose of Cresp in adult patients is 30 μg as Cresp (genetical recombination), to be administered as a single injection once every two weeks subcutaneously or intravenously.

Treatment of Anemia in Cancer Patients Receiving Myelosuppressive Chemotherapy:

Initiate Cresp in patients on cancer chemotherapy only if the hemoglobin is less than 10 g/dL, and if there is a minimum of two additional months of planned chemotherapy.

SIDE EFFECTS

Common side effects are Increased blood pressure, Hypersensitivity.

PACK SIZE

Pack of 1 Vial

Reviews

There are no reviews yet.

Be the first to review “CRESP Darbepoetin Alfa Injection”

Your email address will not be published. Required fields are marked *